Fougera Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Fougera Pharmaceuticals

Access the complete profile.

Fougera Pharmaceuticals Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	One South Ridgedale Avenue East Hanover, NJ 07936

Note: Revenues for privately held companies are statistical evaluations.


Fougera Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Fougera Pharmaceuticals's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Fougera Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Trademark Applications

Trademark applications show the products and services that Fougera Pharmaceuticals is developing and marketing. Fougera Pharmaceuticals doesn't have any recent trademark applications, indicating Fougera Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ELUBRE Pharmaceutical preparations and substances for the treatment and/or alleviation of dermatological diseases, disorders, and conditions	10/19/2011
EPLOVAN Pharmaceutical preparations and substances for the treatment and/or alleviation of dermatological diseases, disorders, and conditions	10/19/2011
FOUGERA PHARMACEUTICALS INC. Pharmaceutical and medicated preparations and substances for the prevention, treatment and/or alleviation of dermatological diseases, disorders and conditions; pharmaceutical and medicated preparations, namely, ointments, creams, gels, lotions, suspensions and solutions for the prevention, treatment and/or alleviation of dermatological diseases, disorders and conditions; oral and topical antibiotics; topical anesthetics; topical corticosteroid preparations; [ medicated pads for the treatment of skin warts; ] medicated preparations for vaginal use, namely, antifungals and anti-infective preparations; sterile surgical lubricant; [ medicinal preparation for use as an antispasmodic and anti-secretory agent; ] pharmaceutical preparations for use as an ear water drying aid	09/09/2011

See all trademarks and details in the Full Report.

Market Share of Fougera Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Fougera Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Fougera Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVARTIS	East Hanover, NJ	100
CELGENE	Summit, NJ	14
ALVOGEN GROUP	Morristown, NJ	13
EXELTIS USA	Florham Park, NJ	2
PHATHOM PHARMACEUTICALS	Florham Park, NJ	1
PHARMAHEALTH LABS	Morristown, NJ	1

Future Competition: Fougera Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Fougera Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)